News alert: Despite a lack of research to back up the move, the FDA has authorized wider use of the drug remdesivir as a COVID-19 treatment

News Alert

Friday, August 28

Despite a lack of research to back up the move, the FDA has authorized wider use of the drug remdesivir as a COVID-19 treatment

Late Friday afternoon, the FDA said it would allow remdesivir to be used on all patients hospitalized with COVID-19, not just those on oxygen. But no research has been published that supports widespread use. It is the second time in a week the FDA has authorized wider use of a COVID-19 treatment without the science to support such a move.

Problem viewing email? View in browser

Unsubscribe • Manage Newsletters • Terms of Service • Privacy Policy/Your California Privacy Rights • Privacy Notice • Do Not Sell My Info/Cookie Policy • Feedback

Pages

News alert: Despite a lack of research to back up the move, the FDA has authorized wider use of the drug remdesivir as a COVID-19 treatment

Belum ada tanggapan untuk "News alert: Despite a lack of research to back up the move, the FDA has authorized wider use of the drug remdesivir as a COVID-19 treatment"

Posting Komentar

News alert: Despite a lack of research to back up the move, the FDA has authorized wider use of the drug remdesivir as a COVID-19 treatment

Postingan terkait:

Belum ada tanggapan untuk "News alert: Despite a lack of research to back up the move, the FDA has authorized wider use of the drug remdesivir as a COVID-19 treatment"

Posting Komentar